Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Mkt Cap
Market Capitalization
₹255Cr
Rev Gr TTM
Revenue Growth TTM
-7.79%
Peer Comparison
Compare up to 10 companies side by side across valuation, profitability, and growth.

NPL
VS
| Quarter | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|
|
Growth YoY Revenue Growth YoY% | | | | | -0.3 | -7.0 | -5.8 | -25.7 | -16.3 | -9.9 | -11.3 | 11.2 |
| 70 | 69 | 73 | 74 | 79 | 64 | 73 | 59 | 76 | 62 | 64 | 62 |
Operating Profit Operating ProfitCr |
| 21.3 | 12.7 | 11.0 | 11.3 | 10.3 | 13.8 | 5.3 | 5.2 | -3.2 | 7.3 | 6.6 | 10.1 |
Other Income Other IncomeCr | 1 | 1 | 2 | 1 | 0 | 2 | 2 | 0 | 0 | 2 | 2 | 0 |
Interest Expense Interest ExpenseCr | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Depreciation DepreciationCr | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |
| 14 | 6 | 6 | 5 | 4 | 7 | 1 | -2 | -8 | 1 | 1 | 2 |
| 3 | 2 | 2 | 1 | 1 | 2 | 0 | 0 | -1 | 0 | 0 | 0 |
|
Growth YoY PAT Growth YoY% | | | | | -71.5 | 12.4 | -84.7 | -131.9 | -311.4 | -82.5 | -42.6 | 220.4 |
| 12.2 | 5.7 | 5.4 | 5.7 | 3.5 | 6.9 | 0.9 | -2.5 | -8.8 | 1.3 | 0.6 | 2.6 |
| 18.8 | 7.9 | 7.7 | 8.3 | 5.3 | 8.8 | 1.2 | -2.6 | -11.3 | 1.6 | 0.7 | 3.2 |
| Financial Year | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|
|
| | | | -11.7 | -13.8 | -3.2 |
| 0 | 0 | 317 | 295 | 272 | 264 |
Operating Profit Operating ProfitCr |
| | | 15.8 | 11.3 | 5.3 | 5.0 |
Other Income Other IncomeCr | 0 | 0 | 21 | 5 | 4 | 4 |
Interest Expense Interest ExpenseCr | 0 | 0 | 7 | 2 | 2 | 1 |
Depreciation DepreciationCr | 0 | 0 | 20 | 19 | 20 | 21 |
| 0 | 0 | 54 | 22 | -2 | -4 |
| 0 | 0 | 14 | 5 | 0 | -1 |
|
| | -15.4 | 4,76,022.9 | -57.5 | -113.4 | -50.5 |
| | | 10.5 | 5.0 | -0.8 | -1.2 |
| -7.2 | -8.3 | 68.7 | 29.2 | -3.9 | -5.9 |
| Financial Year | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|
Equity Capital Equity CapitalCr | 0 | 0 | 6 | 6 | 6 | 6 |
| 0 | 0 | 346 | 353 | 344 | 345 |
Current Liabilities Current LiabilitiesCr | 0 | 0 | 41 | 41 | 37 | 36 |
Non Current Liabilities Non Current LiabilitiesCr | 0 | 0 | 61 | 59 | 56 | 53 |
Total Liabilities Total LiabilitiesCr |
Current Assets Current AssetsCr | 0 | 0 | 114 | 120 | 121 | 123 |
Non Current Assets Non Current AssetsCr | 0 | 0 | 340 | 339 | 321 | 316 |
Total Assets Total AssetsCr |
| Financial Year | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Operating Cash Flow Operating Cash FlowCr | 0 | 0 | 67 | 36 | 19 |
Investing Cash Flow Investing Cash FlowCr | 0 | 0 | 25 | -18 | -2 |
Financing Cash Flow Financing Cash FlowCr | 0 | 0 | -86 | -17 | -13 |
|
Free Cash Flow Free Cash FlowCr | 0 | 0 | 61 | 22 | 14 |
| 0.0 | 95.2 | 169.9 | 216.8 | -831.0 |
CFO To EBITDA CFO To EBITDA% | 0.0 | 95.2 | 112.4 | 96.8 | 122.7 |
| Financial Year | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Valuation Ratios Valuation Ratios |
Market Cap Market CapitalizationCr | 0 | 0 | 0 | 0 | 332 |
Price To Earnings Price To Earnings | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Price To Sales Price To Sales | | | 0.0 | 0.0 | 1.2 |
Price To Book Price To Book | 0.0 | 0.0 | 0.0 | 0.0 | 0.9 |
| 1.4 | 0.3 | 0.3 | 0.0 | 21.1 |
Profitability Ratios Profitability Ratios |
| | | 52.0 | 51.7 | 48.3 |
| | | 15.8 | 11.3 | 5.3 |
| | | 10.5 | 5.0 | -0.8 |
| -256.3 | 150.9 | 16.1 | 6.3 | -0.1 |
| -256.3 | 150.9 | 11.2 | 4.7 | -0.6 |
| -71.9 | -395.2 | 8.7 | 3.7 | -0.5 |
Operational Ratios Operational Ratios |
Solvency Ratios Solvency Ratios |
Liquidity Ratios Liquidity Ratios |
National Peroxide Limited (**NPL**), a flagship member of the prestigious **Wadia Group**, is India’s pioneer and largest manufacturer of **Hydrogen Peroxide**. Following a strategic restructuring effective **April 1, 2022**, the company’s chemical business was demerged and subsequently listed on the **BSE** on **July 4, 2024**. Today, NPL accounts for approximately **50%** of India’s total hydrogen peroxide manufacturing capacity, positioning itself as a critical supplier to the nation’s industrial backbone.
---
### **Core Manufacturing Capabilities & Integrated Operations**
NPL operates a **fully integrated** manufacturing model at its primary facility in Maharashtra. The company is transitioning toward **Industry 4.0** by integrating **AI-driven forecasting**, **IoT-based monitoring** for predictive maintenance, and **automated process control** to optimize yields.
| Feature | Details |
| :--- | :--- |
| **Location** | Kalyan, Maharashtra (Village Vadavali) |
| **Installed Capacity** | **150,000 MTPA** (on a **50% w/w** basis) |
| **Primary Product** | **Hydrogen Peroxide (H2O2)** |
| **Secondary Products** | **Compressed Hydrogen Gas** and **Peracetic Acid (PAA)** |
| **Certifications** | **Responsible Care Logo** (Indian Chemical Council) |
---
### **Product Portfolio & Market Applications**
The company’s portfolio is centered on **green chemistry**, offering non-toxic, biodegradable alternatives to traditional industrial oxidants.
* **Hydrogen Peroxide (H₂O₂):** A versatile oxidative agent that decomposes into water and oxygen.
* **Pulp & Paper:** Primary bleaching agent for paper production.
* **Textiles:** Bleaching agent for cotton and natural fibers.
* **Chemical Synthesis:** Reducing agent for agrochemicals, amines, and aromatic chemicals.
* **Environmental:** Used in Effluent Treatment Plants (**ETP**) and Municipal Sewage Treatment Plants (**STP**).
* **Peracetic Acid (PAA):** A high-growth, **multi-characteristic biocide** (CAGR projected at **10.1%** through 2029).
* **Healthcare & Pharma:** High-quality sterilization and sanitization.
* **Food & Beverage:** Aseptic packaging and disinfection for the processed food industry.
---
### **Strategic Turnaround & Growth Roadmap**
To mitigate its historical reliance on a single product, NPL is executing a diversification strategy aimed at stabilizing long-term profitability.
* **Production Targets:** Aiming for **120,000 MT** in **FY 2025-26**, representing **96%** capacity utilization (a **7%** increase over FY25).
* **Downstream Diversification:** Actively developing H₂O₂ derivatives to reduce concentration risk; new product revenue is targeted to commence in **FY26**.
* **High-Margin Segments:** R&D is focused on **electronic-grade** (for etching/cleaning) and **food-grade** hydrogen peroxide to capture specialty material margins.
* **Global Expansion:** Leveraging the "China+1" supply chain shift to export to over **30 countries**, despite temporary geopolitical headwinds.
---
### **Energy Transition & Operational Efficiency**
Energy and Natural Gas represent **~70%** of NPL's variable costs. The company is aggressively shifting to a sustainable energy model to insulate margins from commodity volatility.
* **Renewable Energy PPA:** NPL holds a **26%** equity stake in **Clean Max Bryce Private Limited** to supply hybrid power.
* **Solar (3.30 MWp):** Operational from **Q3 2025**.
* **Wind (6.6 MVA):** Operational from **Q1 2026**.
* **Target:** Supply **80%** of annual electrical requirements through renewable sources by the end of **FY 2025-26**.
* **Resource Optimization:** Reduced specific power consumption of cooling water pumps from **47 kWh/MT** to **36.7 kWh/MT**.
**Energy Consumption Trends:**
| Metric | FY 2024-25 | FY 2023-24 | FY 2022-23 |
| :--- | :--- | :--- | :--- |
| **Electricity (KWH/MT)** | **360.4** | **371.89** | **373.3** |
| **Natural Gas (MMBTU/MT)** | **0.344** | **0.58** | **0.57** |
---
### **Financial Profile & Capital Structure**
While FY25 saw a contraction in margins due to domestic oversupply and lower realizations (**₹25/kg** vs **₹35/kg** in previous cycles), the company maintains a conservative balance sheet.
| Financial Metric (₹ Crore) | FY 2024-25 | FY 2023-24 |
| :--- | :--- | :--- |
| **Total Income** | **291.36** | **338.15** |
| **EBITDA** | **19.70** | **42.75** |
| **EBITDA Margin** | **6.76%** | **12.84%** |
| **Profit After Tax (PAT)** | **(2.25)** | **16.79** |
| **Net Debt to Equity** | **0.89%** | **1.45%** |
* **Liquidity:** Net cash positive as of **June 2025**. Gross debt reduced to **₹16 crore** in FY25 from **₹23.4 crore** in FY23.
* **Capex:** Planned expenditure for FY26 is capped at **₹10 crore**, funded entirely via internal accruals.
* **Working Capital:** Stable cycle of **45 days**; short-term debt remains at **Nil**.
---
### **Risk Factors & Investment Monitorables**
Investors should note the following headwinds that led to a credit rating revision to **'IND A-' (Negative)** in October 2025:
* **Market Oversupply:** A domestic supply surplus of **40%** has led to aggressive price-cutting by competitors, pressuring EBITDA margins.
* **Input Volatility:** Natural Gas supply is secured via a **"Take or Pay"** contract with **GAIL** through **December 2025**, exposing the company to fixed costs regardless of consumption levels.
* **Geopolitical Impact:** The **Red Sea crisis** contributed to a **50%** decline in export volumes in late 2025.
* **Regulatory/Legal:**
* Settled SEBI orders in early 2025 regarding demerger listing delays and takeover regulation non-compliance.
* Recognized exceptional charges in **Q3 FY26** related to the **Social Security Code, 2020**.
* **Leadership:** **Mr. Rajiv Arora** (CEO & Director) has been re-appointed through **September 2027** to oversee the current diversification and cost-optimization phase.